Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: B cell Lineage Envelope Design from RV144 Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2015-10-05 |
| Study Made Public: | 2016-07-20 |
Title
Neutralization activity of antibodies Ab53042.1 and Ab530402.2, from an RV305 participant, tested against an expanded tier 2 virus panel
Description
CAVD 524 is an immunogenicity study to characterize the neutralization of monoclonal antibodies from a single subject in the RV305 vaccine clinical trial.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.